New Delhi: The government at the Centre on Sunday prohibited the export of injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API) till the COVID-19 situation in the country improves. “All domestic manufactures of Remdesivir advised to display on their website, details of their stockists/distributors to facilitate access to the drug. Drugs inspectors and other officers directed to verify stocks and also take measures to curb hoarding and black marketing,” the Centre said in a statement.Also Read - Remdesivir : Fake vs Real? Watch Video

There is a potential of a further increase in demand for Remdesivir injection in the coming days. Department of Pharmaceuticals has been in contact with domestic manufacturers to ramp up the production of Remdesivir, it added.

The Centre’s decision comes amid an alarming rise of COVID-19 cases in the country. India’s COVID tally has climbed to 1,33,58,805 (1.33 crore, 13.3 million) with a record spike of 1,52,879 daily cases, the Union Health Ministry said on Sunday, in what many say is a second wave that is surging more powerfully than the first.

Earlier on Saturday, the government was alerted about the massive black marketing of Covid drug Remdesivir, which according to some evidence is selling for as high as Rs 50,000, over 10 times of its MRP. In a letter to the Drug Controller General of India (DCGI), LocalCircles has pointed out that over the last 72 hours, once again many posts and comments have been received from various cities of India raising similar concerns and some have even quoted the drug selling for as high as Rs 50,000 over 10 times of the MRP of the drug.

“Once again, certain medical shops have been telling buyers that the medicine is in short supply but can be made available if they are ready to pay a premium,” the letter said.